Prolific Machines
Pre-clinicalDifficult protein production made simple. A next-generation expression system for next-generation therapeutics.
Founded
2020
Focus
Cell TherapySynthetic Biology
About
Difficult protein production made simple. A next-generation expression system for next-generation therapeutics.
Funding History
2Total raised: $97M
Series A$55MThomas TullOct 15, 2023
Seed$42MKhosla VenturesMay 15, 2022
Company Info
TypePrivate
Founded2020
LocationEmeryville, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile